BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
BICYCLE THERAPEUTICS PLC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$3.54+0.08 (+2.17%)
Close on Oct 19, 2026
- Market cap
- $246.76M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
BICYCLE THERAPEUTICS PLC income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -343.6%
- Net margin
- -311.1%
- Return on equity, FY2025
- -31.2%
Financial strength
- Current ratio
- 12.08
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 1070.8%
Valuation
- P/E ratio
- –
- Price to sales
- 4.03
- Price to book
- 0.48
- Dividend yield
- 0.00%